Maryland Psychiatric Research Center

Baltimore, Maryland 21228

0 studies enrolling now · 14 studies all time

What they study most

Cognition, Insulin Resistance, Magnetic Resonance Imaging, Mecamylamine, Nicotine, Schizoaffective Disorder, Schizophrenia, Schizophreniform Disorder

Studies at this site

• Luteolin for the Treatment of People With Schizophrenia — Completed
• Neural Oscillations as Genetic and Functional Biomarkers in Normal and Disease States — Completed
• Salsalate for Insulin Resistance in Schizophrenia — Completed
• Anti-Inflammatory Treatment of Schizophrenia — Completed
• Oxytocin or Galantamine Versus Placebo for the Treatment of Negative Symptoms and Cognitive Impairments in Schizophrenia — Completed
• Varenicline Adjunctive Treatment in Schizophrenia — Completed
• Efficacy Study of Galantamine for Cognitive Impairments in Schizophrenia — Completed
• Clinical Trial of Dipyridamole in Schizophrenia — Completed
• Biomarker Study of Acamprosate in Schizophrenia — Completed
• Oxytocin and CBSST for People With Schizophrenia — Completed
• Nicotinic Enhancement of Cognitive Remediation Training in Schizophrenia — Completed
• Adjunctive Treatment for Decreasing Symptoms of Schizophrenia — Completed
• Nicotinic Modulation of the Default Network — Completed
• A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia — Completed